91
Prevalence of Lysosomal Hydrolase Alpha-glagtosidase Deficiency in Patients With Antiphospholipid Syndrome.
Condition(s):Antiphospholipid SyndromeLast Updated:December 27, 2017Unknown status
Lysine: 425 Clinical Trials, Page 10 of 43
Hide Studies Not Open or Pending
92
Safety, Tolerability and Pharmacokinetics of Liraglutide-depot in Healthy Subjects
Condition(s):Diabetes; Diabetes Mellitus, Type 2; HealthyLast Updated:March 23, 2017Completed
93
Role of Epoxyeicosatrienoic Acids in Chronic Allograft Nephropathy – The TRANSPLANT-EETs Study
Condition(s):Kidney Transplant RecipientsLast Updated:December 7, 2016Completed
94
Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) – COMPOSE
Condition(s):Neuroendocrine TumorsLast Updated:April 21, 2023Recruiting
95
Phase 2 Reduction of Dietary Mycotoxin Exposure by ACCS100″
Condition(s):Dietary CarcinogenesisLast Updated:April 19, 2016Completed
96
Probiotics and Its Associated Factors on Aflatoxin Biomarkers
Condition(s):AflatoxicosisLast Updated:June 21, 2022Completed
97
Safety and Efficacy of Intravenous Tranexamic Acid in Endoscopic Transurethral Resections in Urology
Condition(s):HemorrhageLast Updated:October 11, 2016Completed
98
Effect of Dietary Amino Acid Profile on Lipoprotein Metabolism, Vascular Reactivity and Inflammatory Markers
Condition(s):Hyperlipidemias; Metabolic Syndrome X; Cardiovascular DiseasesLast Updated:May 23, 2014Completed
99
Impact on Risk Stratification of Overlap Syndrome Phenotype in Patients With E1784K Mutation in SCN5A
Condition(s):Long QT Syndrome; Brugada Syndrome; Cardiac Conduction System Disease; Arrhythmias, CardiacLast Updated:October 21, 2022Recruiting
100
Phase I, Dose-Escalation Study of Dihydromyricetin (DHM) to Treat Alcohol-Associated Liver Disease
Condition(s):Alcohol-Related DisordersLast Updated:November 21, 2022Not yet recruiting